EMA Approves Additional Production Site for Johnson & Johnson's COVID-19 Vaccine

MOSCOW (Sputnik) - The European Medicines Agency (EMA) announced on Thursday the approval of another new manufacturing site for Johnson & Johnson's vaccine against COVID-19, as well as increasing the production of the vaccines from Pfizer/BioNTech and Moderna.